Besra Gold Announces Resignation of Director
Melbourne, Victoria, Australia--(Newsfile Corp. - May 21, 2025) - Besra Gold Inc (ASX: BEZ) ("Besra" or the "Company") advises that it has received the resignation of Mr. Chang Loong Lee (Kenny Lee) as a Director of the Company.
Mr. Lee's resignation letter stated:
"After considerable reflection, I have made the difficult decision to resign from my position as a Board member."
"This decision has not been made lightly. My time at Besra has been deeply meaningful, professionally rewarding, personally enriching and built on strong relationships with colleagues I respect greatly. I hold immense admiration for the vision and potential of this organisation and remain proud of what we have achieved during my tenure. It is best to make way for another Director who may strengthen the Board."
"Please be assured that I remain committed to ensuring a smooth transition and will do everything necessary to hand over my responsibilities effectively."
Newly appointed Chair of Besra, Mr. David Potter, stated:
"Kenny's decision to step down from his executive role within the Company was not made lightly. It is a testament to his integrity that he made it independently and with the best interest of Besra's shareholders."
The Board sincerely thanks Mr. Lee for his service and commitment to Besra since his appointment as a Director of the Company in September 2023.
Following the resignation of Mr. Lee, the Board of Besra comprises the following:
David Potter – Non-Executive Chair of the Company
Jon Morda – Non-Executive Director
Sean Williamson – Non-Executive Director
Dato' Lim Khong Soon – Non-Executive Director
This announcement was authorised for release by Mr David Potter – Non-Executive Chair.
Michael Higginson,Company Secretary
N. America Contact:James HamiltonM +1-416-471-4494
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252912
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Taiwan seals Ukraine combat-tested drone software deal to help deter China
(Corrects spelling of family name of official to "Li" not "Lee", paragraph 9) By Ann Wang SUAO, Taiwan (Reuters) -Taiwan sealed a partnership deal on Tuesday with U.S. and German-based Auterion for drone software battle-tested in Ukraine to help strengthen the island's defences against growing military threats from giant neighbour China. Auterion, whose software is used in Ukrainian drones operating combat missions against Russia, said the deal could eventually lead to the technology being used in millions of drones for Taiwan. China views democratically governed Taiwan as its own territory and has ramped up its military pressure over the past five years, including staging half a dozen rounds of war games. Taiwan's government rejects Beijing's sovereignty claims. Since Russia invaded Ukraine in 2022, Taiwan has been studying how Ukraine has deployed drones, both in the air and at sea, to successfully offset Russia's numerical advantage on the battlefield, given China's forces also outnumber Taiwan's. Auterion said it had agreed to a strategic partnership with Taiwan's defence ministry's research and development arm, the National Chung-Shan Institute of Science and Technology, for uncrewed systems and drone swarming software. "What we're bringing to the table has been combat-proven in Ukraine to deter aggression and destroy tanks, naval assets, and other really expensive equipment. So by building a large autonomous fleet, Taiwan can deter China," Auterion's chief executive Lorenz Meier told Reuters. "The partnership is super long-term. So I think in terms of, if you're trying to put that in number of drones or dollars, we're expecting millions of drones eventually over multiple years and hundreds of millions of dollars in value that's being created," he added, speaking at a ministry-organised sea drone exhibition at the northeastern Taiwanese port of Suao. Pushed by the United States, Taiwan has been working to transform its armed forces to be able to wage "asymmetric warfare", using mobile and often cheaper weapons which still pack a targeted punch, like drones and truck-mounted missiles. Chung-Shan President Li Shih-chiang thanked the five foreign companies who participated at the Suao exhibition. "I believe that you will soon be sanctioned by the Chinese government, but do not fear, because you have chosen the democratic camp," he added. Ukraine has deployed sea drones not only to attack ships in Russia's Black Sea fleet, but also to shoot down aircraft. The unmanned sea drones on display in Suao included not only those that could be packed with explosives for high-speed suicide missions, but smaller craft that can conduct low-profile reconnaissance.
Yahoo
8 hours ago
- Yahoo
EZZ Life Science Holdings Limited's (ASX:EZZ) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
EZZ Life Science Holdings' (ASX:EZZ) stock is up by a considerable 35% over the past week. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Specifically, we decided to study EZZ Life Science Holdings' ROE in this article. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. ROE can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for EZZ Life Science Holdings is: 38% = AU$9.0m ÷ AU$24m (Based on the trailing twelve months to December 2024). The 'return' is the income the business earned over the last year. One way to conceptualize this is that for each A$1 of shareholders' capital it has, the company made A$0.38 in profit. Check out our latest analysis for EZZ Life Science Holdings Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. Firstly, we acknowledge that EZZ Life Science Holdings has a significantly high ROE. Secondly, even when compared to the industry average of 8.6% the company's ROE is quite impressive. So, the substantial 41% net income growth seen by EZZ Life Science Holdings over the past five years isn't overly surprising. As a next step, we compared EZZ Life Science Holdings' net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 8.6%. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if EZZ Life Science Holdings is trading on a high P/E or a low P/E, relative to its industry. EZZ Life Science Holdings' three-year median payout ratio to shareholders is 22%, which is quite low. This implies that the company is retaining 78% of its profits. So it seems like the management is reinvesting profits heavily to grow its business and this reflects in its earnings growth number. Besides, EZZ Life Science Holdings has been paying dividends over a period of four years. This shows that the company is committed to sharing profits with its shareholders. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 21% of its profits over the next three years. Regardless, EZZ Life Science Holdings' ROE is speculated to decline to 24% despite there being no anticipated change in its payout ratio. In total, we are pretty happy with EZZ Life Science Holdings' performance. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 hours ago
- Yahoo
ASX Penny Stocks Uncovered: Judo Capital Holdings Among 3 Promising Picks
As Australian shares are expected to edge up slightly, recovering from earlier losses, investors are keenly observing the broader market dynamics influenced by geopolitical developments and commodity price fluctuations. Despite their vintage name, penny stocks continue to offer intriguing opportunities for those interested in smaller or newer companies. With strong financial foundations, these stocks can potentially provide significant returns; this article will explore three such promising examples on the ASX. Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$2.02 A$95.29M ★★★★★★ GTN (ASX:GTN) A$0.62 A$118.33M ★★★★★★ IVE Group (ASX:IGL) A$2.71 A$417.83M ★★★★★☆ GR Engineering Services (ASX:GNG) A$2.97 A$497.04M ★★★★★★ West African Resources (ASX:WAF) A$2.30 A$2.62B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.65 A$436.28M ★★★★★★ Tasmea (ASX:TEA) A$3.12 A$735.14M ★★★★★☆ Lindsay Australia (ASX:LAU) A$0.70 A$222.02M ★★★★☆☆ Bisalloy Steel Group (ASX:BIS) A$3.15 A$149.47M ★★★★★★ CTI Logistics (ASX:CLX) A$1.76 A$141.76M ★★★★☆☆ Click here to see the full list of 1,006 stocks from our ASX Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Judo Capital Holdings Limited operates through its subsidiaries to provide a range of banking products and services tailored for small and medium businesses in Australia, with a market capitalization of A$1.75 billion. Operations: The company generates revenue of A$325.5 million from its banking operations focused on small and medium enterprises in Australia. Market Cap: A$1.75B Judo Capital Holdings Limited, with a market capitalization of A$1.75 billion, focuses on small and medium enterprises in Australia, generating A$325.5 million in revenue from its banking operations. Despite recent negative earnings growth (-22%), the company maintains high-quality past earnings and has not diluted shareholders over the past year. Its Loans to Deposits ratio is high at 128%, but it manages an appropriate level of bad loans (1.2%) with sufficient allowance (111%). The management team and board are experienced, with average tenures of 3.3 and 4.6 years respectively, providing stability amidst market volatility. Jump into the full analysis health report here for a deeper understanding of Judo Capital Holdings. Assess Judo Capital Holdings' future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Kairos Minerals Limited, with a market cap of A$81.56 million, is an Australian resource exploration company operating through its subsidiaries. Operations: Kairos Minerals Limited has not reported any specific revenue segments. Market Cap: A$81.56M Kairos Minerals Limited, with a market cap of A$81.56 million, is pre-revenue and unprofitable but has reduced its losses by 24.9% annually over the past five years. The company is debt-free and boasts short-term assets of A$12.7 million that comfortably cover both short-term (A$312.6K) and long-term liabilities (A$42.2K). It possesses a cash runway exceeding three years based on current free cash flow levels, providing financial stability amidst high weekly volatility of 13%. Both its board and management team are experienced, with average tenures of 3.1 years each, ensuring seasoned oversight during this growth phase. Take a closer look at Kairos Minerals' potential here in our financial health report. Understand Kairos Minerals' track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Renascor Resources Limited focuses on the exploration, development, and evaluation of mineral properties in Australia, with a market capitalization of A$172.93 million. Operations: The company's revenue segment includes exploration activities for graphite, copper, gold, uranium, and other minerals, generating A$0.075 million. Market Cap: A$172.93M Renascor Resources Limited, with a market cap of A$172.93 million, is pre-revenue, generating only A$0.075 million from exploration activities. Despite its high share price volatility and low return on equity (1%), the company maintains financial stability with short-term assets of A$109.8 million exceeding both short-term (A$3.4 million) and long-term liabilities (A$27.9K). The company benefits from being debt-free for the past five years and has an experienced board averaging 14.7 years in tenure, providing strong governance as it progresses its Battery Anode Material project updates and engages in industry conferences. Get an in-depth perspective on Renascor Resources' performance by reading our balance sheet health report here. Assess Renascor Resources' previous results with our detailed historical performance reports. Jump into our full catalog of 1,006 ASX Penny Stocks here. Searching for a Fresh Perspective? We've found 20 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:JDO ASX:KAI and ASX:RNU. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
